Introduction
Since its inception more than 55 years ago, the air pouch model has been linked with cancer research. Hans Selye used the model to study the controversial and contested role of inflammation in tumor development and growth. He generated a proximal and caudal air pouch on dorsal sites in rats and injected these with Walker tumor cell suspensions in combination with irritants or immune suppressants. 1 From these experiments, he concluded that "a topical inflammatory response can greatly enhance the development of transplanted neoplastic tissue," forecasting that specific inflammatory reactions constitute key driver activities in oncogenic processes. 2 Subsequently, Selye's granuloma pouch model was used to study other forms of immunomodulation, for example, by malnutrition and other noxae. 3 Another historical example of air pouch use was the isolation of a tumor angiogenesis factor (TAF) from Walker tumor-elicited ascitic fluid and the demonstration of its angiogenic effect in the rat dorsal air sac assay. 4 The first use of the air pouch model to study infection and inflammation was also a half century ago. 5 On the basis of in-depth histopathological studies, it was concluded that air pouch formation and the infiltration of leukocytes are dynamic processes in need of standardization. The air pouch lining development, including formation of blood vessels and a mechanical barrier to retain products, was found to be ideal at 6 days,
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Vandooren et al and cell infiltration was optimal at 24 hours after product injection. 6 For a considerable time, the rodent air pouch model was assumed to reflect the clinical situation of healing wound cavities after extirpation of organs. 7 Thereafter came a period when it was recognized that this model is useful for the study of immune reactions, bone and cartilage breakdown, and also for drug testing. [8] [9] [10] [11] [12] [13] In addition to cell infiltrations, the production of biological agents, eg, matrix metalloproteinases (MMPs), was studied in the pouch exudates.
14 Rats were used in most of these studies, but these were gradually replaced by mice, coincidently with the explosion of genetic and immunological studies using mice for in vivo testing. 15 Air pouch models were used to study mechanisms of action of drugs, pharmacokinetics, enzyme induction or inhibition, regional drug delivery, angiogenesis, and cell migration. 7, 14, [16] [17] [18] [19] [20] [21] [22] Gradually, the mouse air pouch model became a standard test in pharmacological, immunological, and biomaterials research. [23] [24] [25] [26] [27] With the application of the mouse air pouch model, genetic factors, including those encoding cytokines, proteinases and other enzymes, and adhesion molecules were identified in inflammation; the combination with spontaneous gene deficiencies or gene knockout technology further enhanced insights into inflammatory processes. [28] [29] [30] [31] [32] [33] With the introduction of nanomedicines, the awareness of immunomodulating effects has increased but still remains problematic and challenging. Laboratories are collaborating worldwide to define, compare, and validate, not only toxicology tests, but also assays to measure effects of nanoparticles on immune responses. 34 At present, in vivo and ex vivo immunological analysis of injected nanoparticles is done by studying white blood cells and the histopathology of immune organs. Blood analysis yields a partial picture, and histopathology is time consuming and not quantitative. For immunological screening of nanomedicines, these tests are important but not sufficient -for at least three reasons. First, all viruses, except the largest (pox and pandora) viruses, are (replicating) nanostructures that exert profound immunological effects in vivo, even after being completely inactivated, for instance, in vaccines. Nanoparticles, in particular those that are (un) purposely coated with proteins or those having nucleic acids, are therefore virus mimetics. It is generally accepted that pattern recognition receptors, such as Toll-like or retinoic acid-inducible gene (RIG)-like receptors, induce the immediate innate immune response to nanoparticulate viruses. Nanoparticles also help with ensuing adaptive responses to generate antigen-specific T cell responses and antibody formation by B lymphocytes. In addition, specific cell types in organisms can sense the size of particles (infectious agents range in size from nanometers for viruses, micrometers for bacteria and parasites, to millimeters, centimeters, or even meters for worms). Second, host immunity is by definition based on organ systems that cannot be replaced by single cells. For instance, antigenicity is tested by the ability to form antibodies in vivo; such a test is difficult to reproduce in vitro. Third, the available in vivo toxicity tests for nanoparticles include skin painting, inhalation (airway provocation), and ingestion. These tests are excellent means by which to establish safety measures against potential dangers of professional exposure of workers in research and manufacturing. However, in all the aforementioned cases, epithelial barriers of skin and mucosa are involved. Most nanomedicines will, in practice, be used by injection and therefore will first encounter leukocytes, and endothelial and mesothelial cells, rather than epithelial cells. For these reasons, a profound need exists for one or more standard tests that can measure various aspects of immunological responses. In view of increasing biomedical applications of nanoparticles as drugs or imaging tools, immunotoxicity analysis needs standardization. 35, 36 In this study, we present data on the use of air pouch analysis of nanoparticles toward this goal.
Materials and methods
The mouse air pouch model A general outline of the method used is shown in Figure 1A . Dermal air pouches were established by injecting Naval Medical Research Institute mice on dorsal sites with 3 mL filtered air (0.20 µm filter) on days 0 and 3. 37 On day 6, the test samples were injected, along with a negative and a positive control sample. Phosphate-buffered saline (PBS) was used as a negative control and chlorite-oxidized oxyamylose (COAM) as a positive control, for neutrophil recruitment. 38 After 24 hour contact, the exudates of the pouches were collected after injection of 1 mL pyrogen-free PBS containing heparin 20 U/mL and 2% fetal calf serum (FCS), and followed by 30 seconds of gentle massage. This procedure was repeated twice with 2 mL buffer, and the total exudate collection was centrifuged (10 minutes, 900 rpm). The numbers of viable cells were determined in a Bürker chamber after trypan blue exclusion of dead cells and were resuspended for immediate hemocytometry and cytospin analysis. The supernatant fluids were frozen (-20°C) for gelatin zymography. 39 Each sample was tested for contamination with endotoxin using the Limulus amebocyte lysate test (Cambrex Bio Science, Baltimore, MD, USA). All procedures were conducted in accordance with protocols approved by the local Ethics Committee (Licence number P028/2013, Belgium). All materials were tested on three to five mice. In addition, the statistical analysis and the repeat numbers of the positive (COAM) and negative (PBS) controls have been indicated in Table 1 . Finally, most nanoparticles were tested twice (with similar results), depending on material availability.
Differential cell counts
Differential cell counts were based on morphologic examination of cytospin preparations stained with Hemacolor (Merck Chemicals, Darmstadt, Germany). 75 × 10 3 cells were applied onto slides by centrifugation using a Shandon Cytospin 2 apparatus (Thermo Shandon, Pittsburgh, PA, USA).
Flow cytometry analysis
To corroborate hemocytometric analyses, we also performed flow cytometry analysis. The rationale for this was two-fold. First, many laboratories are equipped with cytometers to differentiate by immunophenotyping cell numbers in an efficient way. Second, it was used to validate the more labor-intensive microscopic quantification. We incubated 5 × and data were processed with the manufacturer's CellQuest software. 38 
gelatin zymography
Gelatin zymography was used to measure the presence of the MMP-2 and the inducible MMP-9. 39, 40 All samples were first prepurified by gelatin-Sepharose affinity chromatography, as described in a previous publication. 41 Next, the proteins were separated in 7.5% polyacrylamide gels to which 0.1% gelatin (Sigma-Aldrich, St Louis, MO, USA) was added and copolymerized. After electrophoresis, the gels were washed to remove sodium dodecyl sulfate and incubated for the development of zymolytic bands. The gels were stained with Coomassie brilliant blue R-250 (Sigma-Aldrich).
Results

Validation of the mouse air pouch model
First, the use of COAM as a positive control substance was evaluated ( Figure 1B-E) . Injection of COAM resulted in a dose-dependent increase in the number of total viable cells. Differential cell counts revealed that mostly neutrophils migrated into air pouches. Therefore, in all forthcoming experiments 2 mg of COAM was used as a positive control for neutrophil recruitment. Upon collection of the samples, we first counted and differentiated the cells by classical hemocytometric analysis. With this approach a trained microscopist can differentiate neutrophils from monocytes/macrophages and lymphocytes, and this technique does not necessitate the purchase of expensive equipment. To validate this approach and to demonstrate that, alternatively, flow cytometric analysis with the use of cell-specific antibodies is another way of quantification, correlation analysis was done for neutrophil and mononuclear cell counts for both techniques ( Figure 1F and G). Our data indicate that both methods are suitable for 
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Intradermal air pouch leukocytosis as an in vivo test for nanoparticles quantification and differential cell counting of specific leukocyte subsets, and that more sophisticated and high-end cell differentiations with flow cytometric analysis are possible.
analysis of differently sized polystyrene particles
In a first set of experiments we evaluated the effect of polystyrene particles of different sizes on the recruitment of leukocytes and the content of gelatinases (MMP-2 and MMP-9). Because MMP-9 is highly expressed by leukocytes upon an inflammatory stimulus, we hypothesized that immunemodulating substances would increase the ratio of MMP-9/ MMP-2. 40, 42 Indeed, in gelatin zymography analysis, 39 MMP-2 is found constitutively expressed in most tissues and body fluids. Consequently, MMP-2 may be used as an internal reference enzyme. In contrast, MMP-9 is an inducible enzyme in cancer, infection, and inflammation, which makes the MMP-9/MMP-2 ratios indicative for neoplastic, infectious, or inflammatory processes. Whereas COAM and polystyrene nanoparticles induced more than a doubling in the numbers of total retrieved cells in comparison with PBS control samples, the microspheres did not (Figure 2A ). When we differentially counted leukocytes in this pilot experiment, we observed twice as many neutrophils after nanoparticle and microparticle injection than with the PBS control, which recruited more mononuclear cells (Figure 2B and C) . Zymography analysis of the exudate fluids demonstrated a clear induction of gelatinase B/MMP-9 by COAM and by the polystyrene nanospheres, but less with microspheres. As expected, the cellular infiltration was correlated with the induction of MMP-9; these findings illustrated the inflammatory context of air pouches at the molecular level after injection of COAM ( Figure 2D and E). (Table 1 and Supplementary  materials) . First, all samples were tested for contamination with endotoxin. Most particles did not exceed the endotoxin limit of 100 pg/mL (US Food and Drug Administration standard for substances in direct/indirect contact with the cardiovascular system or lymphatic system). However, several nanoparticles attracted higher percentages of neutrophils, resulting in higher total cell counts in comparison with the negative control.
Discussion
Most reviews on safety, toxicity and immunological effects of nanoparticles use in vitro analyses. Without any doubt, such tests are paramount and essential first-line analytical tools for the measurement of cytotoxicity and eventual metabolic effects. [34] [35] [36] However, the effects of nanoparticles on in vitro cultured macrophages, dendritic cells, neutrophils, and lymphocytes, in terms of release of inflammatory (eg, prostaglandins) or immunological mediators (eg, enzymes and cytokines) are insufficient to determine immunotoxicity.
The next step, second-line analytical tools for in vivo testing, logically starts with the analysis of blood components. Hematological parameters should include effects on the clotting and fibrinolytic systems, and blood cell counts for erythrocytes (hemolysis), platelets and leukocytes. Immunological parameters, such as complement pathway tests, immunoglobulin levels, and FACS analysis of leukocyte subsets, may be added to immunological tests for nanoparticles. Another second-line immunological test may consist of histopathology analysis of immune organs, including bone marrow, thymus, lymph nodes and spleen. Practically, however, this constitutes a time-consuming and high-end analysis needing the expertise of well-trained pathologists. [34] [35] [36] Therefore, a second-line in vivo test, amenable to standardization and routine analysis is proposed. The air pouch model fulfills the criteria as such a test for several reasons: 1) it constitutes a surrogate test for histopathology analysis of immune reactions including tissue inflammation; 6 2) dependent on the execution and standardization, it yields (semi-) quantitative results in the form of absolute and relative leukocyte counts; 3) it can be used to study acute and chronic immune reactions; 4) it can be executed with limited costs and in simple laboratory environments by well-trained technicians, and with basic infrastructure; and 5) it can even be used to test the effects of (immunomodulating) gases, such as NO or H 2 S, or of nanoparticles that might generate gases by catalysis.
An important issue to address is the minimization of use of mammalian hosts for in vivo testing. Unfortunately, immunological testing requires in vivo experiments, but in practice the air pouch test yields solid and reproducible data with minimally three mice per test sample. Although we propose to use the air pouch leukocytosis analysis as a standard technique for in vivo testing of nanoparticles and suggest using buffer conditions as negative and COAM as positive controls, we acknowledge that additional studies will demonstrate its value. Figure 1B -E illustrates the variability within groups of five mice, whereas the statistical analysis of the PBS and COAM controls in Table 1 (seven groups, three mice per group) illustrates the reproducibility. Many mouse strains are genetically and immunologically well characterized and can be housed in a cost-effective way in comparison with larger mammals. Also, it needs to be stated that with the mouse air pouch model, the distress and suffering of the animals is limited in comparison with efficacy testing of nanoparticles, for instance, in mouse tumor models. As alternative to the air pouch test, we also used intraperitoneal injection. 43 Because the peritoneal cavity is a larger space, dilution of samples occurs and, in addition, sample retrieval is more variable and demands better skills. The air pouch test can be executed by any well-trained scientist and, in principle, does not need sophisticated equipment. In addition, analysis methods on retrieved cells and exudate molecules can be upgraded to high-end cyto metry and molecular analysis, including RNA sequencing, proteomics, and glycomics analysis. This is here illustrated with one analysis of gelatinases by zymography. 39 As is the case of in vitro tests, any in vivo test will have limitations. Coating with host molecules (eg, nanoparticle corona) may lead to immunological side effects in vivo. 34 In contrast to organic biodegradable nanoparticles, including small virus particles, many nanoparticles with inorganic cores are not degradable, may persist and yield chronic deposition in tissues, sterile granuloma formation, and fibrosis. These aspects, and comparisons between degradable and nondegradable particles, may also be studied in the future by observations of air pouches after prolonged time intervals.
Conclusion
We conclude that standardized air pouch leukocytosis analysis fulfills the criteria as a test for innate immune functions and is also amenable for analysis of changes in adaptive immune functions, and we advocate the use of this analytical method. With microbial, pyrogenicity, 
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Intradermal air pouch leukocytosis as an in vivo test for nanoparticles cytotoxicity and in vitro immunological tests (eg, cytokine induction on specific cells) as first-line assays, the dermal air pouch analysis is -in addition to hematology parameters -a valuable tool to be implemented as second-line assay for all present and future nanomedicines. Experimental animal models for human disease are necessary for medical progress toward better diagnosis, prognoses, and therapies. Awareness of ethical issues has progressively diminished the use of mammalian vertebrates and led to a switch towards the use of frogs, zebrafish, worms, snails, and flies. Although ortholog models for many diseases already exist in these species, in particular for neurobiological research, for immunological evaluations and research such species replacement strategy is not broadly applicable. Because inflammation and adaptive immune mechanisms are increasingly being found to be important in tumor biology and nanoparticles are hailed as carriers for new cancer drugs, nanoparticle research for oncology applications needs to rely on evaluations by mammalian host experiments -such as the air pouch test. We recommend using only those nanoparticles parenterally (eg, for diagnostic purposes) that yield air pouch leukocytosis, equivalent to the negative PBS control. 
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